Fig. 2From: Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort studyProgression-free survival (months) after ASCT according to renal function groups. Group A: eGFR always > 60 ml/min/1.73m2; Group B: eGFR < 60 ml/min/1.73m2 at diagnosis improving to > 60 ml/min/1.73m2 before ASCT; Group C: eGFR always < 60 ml/min/1.73m2Back to article page